MedTrace Logo

BETA - Pilot Study

NCT07192861 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2025-09-25

No results posted yet for this study

Summary

This study is testing the feasibility of using non-invasive, remote digital tools including continuous glucose monitors (CGMs) and Oura ring and the Empatica EmbracePlus smart wristband to predict the function of beta-cells, the cells in the pancreas that secrete insulin. This study is being initially done with individuals with Type 1 diabetes, so that in the future these methods can be tested in a larger study of individuals with Type 2 diabetes or prediabetics. The eventual aim of this work is to develop remote digital tools that can predict the health and functioning of the pancreas in people with prediabetes and Type 2 diabetes, allowing personalized treatment approaches to preserve insulin secretion.

Conditions

  • Diabetes (DM)

Sponsors & Collaborators

  • Buck Institute for Research on Aging

    collaborator OTHER

  • Phenome Health

    collaborator UNKNOWN

  • 4YouandMe

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07192861 on ClinicalTrials.gov